Gut inflammation in PCC is also suggested by a proteomic study observing increased DPP10 (a modulator of tissue inflammation that is associated with inflammatory bowel disease) in PCC patients compared to non‐PCC controls [45]. This evidence concerns the gene DPP10 and adrenal gland pheochromocytoma.